Danicamtiv clinical trials
Also written MYK-491 and BMS-986434.
How each study uses danicamtiv is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the danicamtiv studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Bristol-Myers Squibb (5) · Kardigan, Inc. (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test danicamtiv, phase 3 first.
- Sep 2027A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated CardiomyopathyPhase 2/3 · Kardigan, Inc.
Studies
Open first, then newest update. How each study uses danicamtiv is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated CardiomyopathyRecruitingPhase 2/3Kardigan, Inc.NCT07210723Written as danicamtiv
- A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated CardiomyopathyRecruitingPhase 3Kardigan, Inc.NCT07771465Written as Danicamtiv
- Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other CausalitiesTerminatedPhase 2Bristol-Myers SquibbNCT04572893Written as danicamtiv
- A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05806359Written as Danicamtiv
- A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart FailureCompletedPhase 1Bristol-Myers SquibbNCT05952089Written as Danicamtiv
- A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT06027437Written as Danicamtiv
- v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491CompletedPhase 1/2Bristol-Myers SquibbNCT03447990Written as MYK-491
Given beside what is tested · 1 — danicamtiv is usual care or a partner of the new treatment
Codes
What other systems call danicamtiv · ClinicalTrials.gg INT002199
- MeSH (NLM) C000732026danicamtivOne source NLM
- UNII (FDA) 7B2CS922HIDANICAMTIVConfirmed FDA, NLM, Wikidata
- Wikidata Q123907335danicamtivConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C167013DanicamtivOne source FDA
- DrugBank DB18962One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000732026 | danicamtiv | One source NLM |
| UNII (FDA) | 7B2CS922HI | DANICAMTIV | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q123907335 | danicamtiv | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C167013 | Danicamtiv | One source FDA |
| DrugBank | DB18962 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.